The growth of the genomics market is driven by the rising prevalence of genetic disorders and cancer, along with increasing awareness of early disease detection through genetic testing. WILMINGTON, ...

Prenatal imaging identified situs inversus totalis, and whole exome sequencing found DNAH11 variants. The case highlights how ...

Comprehensive residue-level mapping of amyloid-beta recognition reveals how sequence variants, post-translational ...

Twist Bioscience Corporation (NASDAQ:TWST) Q1 2026 Earnings Call Transcript February 2, 2026 Twist Bioscience Corporation ...

Genomics company Illumina (NASDAQ:ILMN) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 5% year on year ...

With Q3 behind us, let’s have a look at Illumina (NASDAQ:ILMN) and its peers. The life sciences tools and services sector supports biotech and pharmaceutical R&D and commercialization by providing lab ...

Twist Bioscience Corporation Q1 2026 revenue rose 17% and guidance increased. Click for this updated look at TWST stock ...

For instance, some products that are used to perform various in vitro diagnostic tests using various technologies involve real time PCR detection systems, immunoassay systems, and others. In vitro ...

Philip Awadalla has been studying population genetics for decades, and is still amazed at what scientists have learned from comparing genomes at scale. “There have been massive advancements in our ...

“In GA, light is not transduced into electrical signals because of a loss of photoreceptors, which leads to an absolute scotoma (blind spot). 2,3 The PRIMA neurostimulation system replaces the lost ...

A Florida state legislator sponsored the nation's first state-backed genetic screening program after his son died from a rare genetic disease.